Form 8-K - Current report:
SEC Accession No. 0001193125-22-046719
Filing Date
2022-02-18
Accepted
2022-02-18 17:09:36
Documents
17
Period of Report
2022-02-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d309078d8k.htm   iXBRL 8-K 37983
2 EX-10.1 d309078dex101.htm EX-10.1 13356
3 EX-10.2 d309078dex102.htm EX-10.2 98720
4 EX-10.3 d309078dex103.htm EX-10.3 38515
5 EX-10.4 d309078dex104.htm EX-10.4 35979
6 EX-10.5 d309078dex105.htm EX-10.5 88471
  Complete submission text file 0001193125-22-046719.txt   519438

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA lyra-20220216.xsd EX-101.SCH 2872
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lyra-20220216_lab.xml EX-101.LAB 17979
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lyra-20220216_pre.xml EX-101.PRE 11269
11 EXTRACTED XBRL INSTANCE DOCUMENT d309078d8k_htm.xml XML 3342
Mailing Address 480 ARSENAL STREET WATERTOWN MA 02472
Business Address 480 ARSENAL STREET WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 22653796
SIC: 3841 Surgical & Medical Instruments & Apparatus